Michelle Felicia Lee
Overview
Explore the profile of Michelle Felicia Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
43
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee M, Long C, Poh C
Vaccine X
. 2025 Jan;
22():100604.
PMID: 39830640
Dengue fever is caused by the mosquito-borne dengue virus (DENV), which is endemic in more than 100 countries. Annually, there are approximately 390 million dengue cases, with a small subset...
2.
Lee M, Anasir M, Poh C
J Pharm Sci
. 2023 Dec;
113(3):587-595.
PMID: 38103687
Dengue presents a major public health concern in over 100 countries due to the absence of an effective vaccine and antiviral therapy against all four dengue virus (DENV) serotypes. Several...
3.
Abd-Aziz N, Lee M, Ong S, Poh C
Virology
. 2023 Nov;
589:109941.
PMID: 37984152
The hand, food, and mouth disease (HFMD) is primarily caused by Enterovirus A71 (EV-A71). EV-A71 outbreaks in the Asia Pacific have been associated with severe neurological disease and high fatalities....
4.
Lee M, Wu Y, Poh C
Viruses
. 2023 Mar;
15(3).
PMID: 36992414
Dengue is a major global health threat causing 390 million dengue infections and 25,000 deaths annually. The lack of efficacy of the licensed Dengvaxia vaccine and the absence of a...
5.
Lee M, Poh C
Pharm Res
. 2023 Mar;
40(3):617-632.
PMID: 36869247
Peptides are a rapid-growing class of therapeutics with unique and desirable physicochemical properties. Due to disadvantages such as low membrane permeability and susceptibility to proteolytic degradation, peptide-based drugs have limited...
6.
Lee M, Anasir M, Poh C
Virology
. 2023 Feb;
580:10-27.
PMID: 36739680
Dengue infections pose a critical threat to public health worldwide. Since there are no clinically approved antiviral drugs to treat dengue infections caused by the four dengue virus (DENV) serotypes,...
7.
Lee M, Voon G, Lim H, Chua M, Poh C
Front Cell Infect Microbiol
. 2022 Oct;
12:1004608.
PMID: 36189361
Dengue is a mosquito-borne disease which causes significant public health concerns in tropical and subtropical countries. Dengue virus (DENV) has evolved various strategies to manipulate the innate immune responses of...